Former corporate strategy and private equity executive focused on growth-stage technology and healthcare investments, with experience sourcing deals, leading diligence and advising portfolio operations. Samantha Cox leverages operating background at multinational corporations and venture-backed scaling teams to evaluate go-to-market and unit-economics risk. Active in venture and growth funds, known for sector diligence, founder engagement and value-creation plans.
Former corporate strategy and private equity executive focused on growth-stage technology and healthcare investments, with experience sourcing deals, leading diligence and advising portfolio operations. Samantha Cox leverages operating background at multinational corporations and venture-backed scaling teams to evaluate go-to-market and unit-economics risk. Active in venture and growth funds, known for sector diligence, founder engagement and value-creation plans.
Combines operational rigor with growth-stage investing, prioritizing businesses where repeatable go-to-market motion and defensible unit economics can be scaled. Emphasizes founder partnerships, hands-on diligence, and operational value creation—aligning capital with clear KPIs (CAC, LTV, margin expansion). Prefers technology-enabled healthcare and SaaS sectors, uses stage-agnostic check sizes across venture and growth to de-risk scaling milestones, and maintains disciplined downside protection via covenanted governance and milestone-based tranches.
Combines operational rigor with growth-stage investing, prioritizing businesses where repeatable go-to-market motion and defensible unit economics can be scaled. Emphasizes founder partnerships, hands-on diligence, and operational value creation—aligning capital with clear KPIs (CAC, LTV, margin expansion). Prefers technology-enabled healthcare and SaaS sectors, uses stage-agnostic check sizes across venture and growth to de-risk scaling milestones, and maintains disciplined downside protection via covenanted governance and milestone-based tranches.
| Trades 1207 | Longs Won 887/1207 73% | Profit Factor 8.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $677,484.58 |
| Average Win $223,174.71 | Best Trade (Jul 16) $10.52M | Sharpe Ratio -8.5 |
| Average Loss -$71,939.86 | Worst Trade (Jul 16) -$2.83M | Z-Score 12.65 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 3w 6d | Expectancy $144,933.89 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 10,989 | 9,890 | 8,791 | 7,692 | 6,593 | 5,495 | 4,396 | 3,297 | 2,198 | 1,099 |